Age Related Macular Degeneration (ARMD) Recruiting Phase 2 / 3 Trials for Ranibizumab (DB01270)

Also known as: Age Related Macular Degeneration

IndicationStatusPhase
DBCOND0055169 (Age Related Macular Degeneration (ARMD))Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02296567Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration PatientsBasic Science